Kidney paired exchange (KPE) constitutes 12% of all living donor kidney transplantations (LDKTs) in the United States.
The advent and growth of kidney paired exchange (KPE) in the United States has provided increased transplant options for patients with ABO incompatible (ABOi) and human leukocyte antigen (HLA) incompatible living donors (Fig. 1) . First initiated as simple 2-way exchanges between 2 incompatible pairs, exchanges have grown more complex with swaps between 3 or more pairs. With growth in KPE volume, development of logistical support, strengthening of matching algorithms, demonstration of safety, and increasing comfort by surgeons and nephrologists with this form of transplantation, the variations in KPE have multiplied, thereby allowing additional pairs to participate. It is now routine for domino chains to be initiated by an altruistic nondirected kidney donor. These chains may be simultaneous where all of the transplants occur over a period of 1 to a few days or nonsimultaneous extended chains. (4) (5) (6) In the nonsimultaneous setting, bridge donors may wait days to months until additional pairs are added to the chain. In either scenario, most chains are ultimately ended with donation of a living donor kidney to a recipient on the deceased donor list.
In KPE, the frequency of a match for an incompatible pair is improved when compatible pairs are added to the pool of incompatible pairs. This allows individuals who are sensitized to HLAs or are ABOi access to a greater number of potential donors. Some transplant programs encourage all compatible pairs to enroll in a KPE program in order to increase the pool of potential donors for hard to match recipients. (7) Uniform agreement on this practice does not exist, and some providers would argue that a compatible pair should only participate in an exchange if there was some benefit to the recipient, primarily a better HLA match or an organ from a younger donor. Initially, KPE was performed within a single transplant center or a coalition of several centers. Although some centers continue to perform KPE within their own patient population or with centers in geographic proximity, patients may be disadvantaged by this approach due to less exposure to potential compatible matches. Given the benefit of a large number of incompatible and compatible pairs available to participate in an exchange, and the effort and resources required to maintain an exchange network, within the past several years, KPE has consolidated to primarily 3 consortia: the National Kidney Registry, the KPE program from the United Network for Organ Sharing (UNOS), and the Alliance for Paired Donation. Each consortium has established its own separate rules and regulations for managing participating pairs and transplant centers, unique algorithms for matching, and organizing the logistics of a swap. Transplant centers upload data on the donor and the intended recipient into a centralized computer system run by the consortia including detailed HLA information, renal anatomy, and renal function. As new pairs are added, the matching algorithm is rerun, facilitating the greatest number of transplants. (8) (9) (10) When a match is found from within the centralized repository of donor and recipient pairs, the transplant centers are notified, at which time the center examines the appropriateness of the donor for their recipient in detail, including imaging and HLA data. The coordination of the movement of kidneys around the country requires detailed planning among centers. Commercial air transport is primarily used for donor and recipient centers that are too distant for ground transportation.
One of the initial concerns with KPE was the risk that a donor might back out of an exchange, leaving the recipient of the opposite pair without a transplant. (11) To decrease this risk, the initial 2-way swaps were coordinated so that the donors at different centers were in the operating room at the same time. As transplant centers became more comfortable with KPE, and the complexity of these exchanges increased over distance and over an extended duration through nonsimultaneous chains, the temporal initiation of donor surgery has become less of a concern, although when feasible, attempts are made for the donor to proceed with surgery prior to or simultaneously with the donor of the unmatched pair. Occasionally, donors are unwilling or unable to proceed due to a change in desire to donate or unanticipated health or family circumstances. (12) In such situations, attempts are made to obtain an organ for the nontransplanted recipient by ending a chain with that patient.
Establishing the Need for LPE
An inadequate supply of donor organs, whether from a deceased or living donor, is the impetus to consider innovative methods to increase the quantity of liver allografts through LPE. In the United States, approximately 3000 patients are removed from the liver waiting list each year because they become too ill or die prior to receiving a liver transplant. (13) In some transplant centers, more than 25% of the population on the waiting list do not survive to transplant. Living donor liver transplantation (LDLT) is 1 method to rectify the inadequate supply of liver allografts and has been shown to provide a survival advantage compared with remaining on the waiting list, even for those with low Model for End-Stage Liver Disease (MELD) scores. (14, 15) Although LDLT is the established primary source of donor allografts in many parts of Asia, LDLT constitutes approximately 4% of liver transplants in the United States, signifying the prospects for increased growth in living donation. (13) The potential number of donor and recipient pairs that might be suitable for LPE in the United States is unknown and is dependent on numerous factors. However, the Asan Medical Center experience from South Korea provides some perspective; among 2182 LDLT patients, 26 involved LPE. (3) In the United States, most donors selected for LPE will likely be those where the donor is appropriate to donate with regard to the usual anatomical, medical, and psychosocial dimensions, but for 1 reason or another not appropriate for his or her intended recipient. Centers that evaluate living liver donors follow a stepwise approach to determining eligibility for donation. Some donors are rejected early in the evaluation process for obesity or other comorbidities, age, or being psychosocially unfit to proceed with donation. (16, 17) Those who pass the initial screening process are assessed further for blood type, liver volumes, and other anatomical considerations, as well as general medical and psychosocial concerns. The donors who are rejected at this stage in the evaluation are the ones who could be considered for LPE. It is estimated that 3.5%-17.0% of donors are rejected for ABOi, 4.1%-14.0% for inadequate hepatic mass to support the recipient, and 1.5%-6.0% due to vascular or biliary anatomic variations. (17) (18) (19) (20) There is considerable variation of these estimates based on the order of tests and the screening processes used to evaluate potential donors based on transplant center-specific donor criteria. These barriers to donation represent opportunities for a variety of exchanges between donor and recipient pairs, such that the total number of lives saved through LDLT could be increased.
Potential Indications for LPE

ABO INCOMPATIBILITY
ABOi is perhaps the most recognizable reason for not considering a potential living donor (Table 1 ). In the largest series of living donor liver exchanges, ABOi was the indication for 85% (n 5 22) of the transplants. (3) ABOi deceased donor liver transplants are associated with a greater incidence of diffuse biliary strictures and in some series, inferior allograft survival, among adult recipients, but not young children. (21) (22) (23) Several published series provide evidence of success among ABOi LDLT when there is modification of the preoperative and perioperative immunosuppression regimen with attention to isoagglutinin titers, but with an associated increased incidence of biliary complications. (21, (24) (25) (26) Furthermore, ABOi LDLT may not be ideal in certain clinical scenarios, particularly if the recipient has acute-on-chronic liver disease. (3) Except for young children, ABOi LDLT has not been performed in the United States, although 14 A2 donors have been used in non-A recipients (according to Organ Procurement and Transplantation Network/ UNOS data as of June 3, 2017) . LPE therefore remains a viable option for centers willing to undertake the logistical challenges involved with LPE, avoiding the potential risks of ABOi LDLT.
HEPATIC MASS
There are 3 potential scenarios where hepatic mass may influence the decision to proceed with LPE:
1. The donor allograft segment is small relative to recipient weight, and there is concern for early allograft dysfunction (EAD), also termed smallfor-size syndrome. 2. The donor allograft segment is too large for the recipient, which is more likely to occur with small pediatric recipients. 3. The donor's estimated remnant hepatic volume is felt to be inadequate. (27) (28) (29) (30) (31) (32) Although some centers are willing to use small grafts relative to recipient size with graft-to-recipient weight ratios (GRWRs) of <0.6%-0.8% and a graft weight/standard liver volume ratio of <40%, this has not been widely practiced. Some have advocated for performing a variety of graft inflow or pharmacological interventions to reduce portal flow in order to avoid EAD, but the value of such procedures/interventions are debated. EAD risk is not based simply on graft size, but also includes factors such as donor age and recipient disease severity, which may influence the decision with respect to GRWR and any potential benefit of participation in LPE. (33) 
ANATOMICAL VARIATION
Hepatic arterial and biliary anatomy demonstrate a large number of variations. (34) Donors who have The biliary reconstruction is recognized as the source of greatest morbidity in the recipient following LDLT. Multiple ducts have been identified as a risk for biliary complications and surgeons generally try to avoid multiple biliary anastomoses, as this can impact recipient morbidity, need for subsequent procedures, and rarely, mortality. (35, 36) In some circumstances, LPE could impact the choice of lobe and reduce complex recipient biliary reconstructions and possibly minimize posttransplant complications if donor and recipient matching reduces the need for complex biliary anastomoses.
Examples of Potential LPE
In the following section, we provide some examples of potential LPE. If the history of KPE serves as a guide for the trajectory of LPE, the number of pairs involved, the indications for participation, and the complexity of exchanges are likely to increase (Fig. 2 ).
1. Two-way swap: ABOi pair and a pair where the estimated weight of the donor lobe is inadequate for the intended recipient ( Fig. 2A ). 2. Three-way swap: ABO compatible pair where the remnant volume is too small for the donor; ABOi donor to small child where the left lateral segment (LLS) is also too large for the child; and an ABOi pair (Fig. 2B ). 3. Nondirected donor starts a chain (Fig. 2C ).
Patient with familial amyloid polyneuropathy (FAP)
receives a deceased donor organ or LDLT and starts a chain with a domino liver (Fig. 2D ). LPE may offer a variation on KPE chains because those recipients with FAP or other rare genetic disorders who receive a LDLT or deceased donor transplant can domino their own liver within a chain. (37) This has added attraction given that nondirected living liver donation is not currently considered mainstream.
LPE Hurdles, Logistics, and Feasibility
The primary hurdles of initiating LPE are anticipated to be both similar and very different than KPE. In this section, we consider some of the barriers to initially performing LPE and offer potential solutions ( Table  2) . With KPE, the original effort was very much organic, arising within transplant centers or small collections of centers. We would anticipate that LPE would start either within a single center, or between centers that are within geographic proximity and whose surgical teams have an established relationship.
The initial approach might be constricted by the number of transplant surgical teams with experience in LDLT and the small number of centers that perform LDLT. In 2016, 45 centers in the United States performed a LDLT, of which only 12 performed more than 10 transplants. Given the association between center LDLT volume and posttransplant outcomes, early participation by centers with greater LDLT experience is essential. (38, 39) Ultimately, LPE is also limited by the relatively small total volume of LDLTs, which is to some extent encumbered by the increased risk of mortality for liver donation compared with kidney donation (estimated 0.5% for right liver lobe donor versus 0.03% for living kidney donor).
As with the initial experience with KPE, it is anticipated that LPE would begin with 2-way swaps, the simplest form of exchange. If the donor procedures were performed at separate institutions, each center would thoroughly review and vet the predonation evaluation from the other center and concur that the donor was adequate for their recipient. Before proceeding to the operating room, the teams should establish intraoperative plans for the donor hepatectomy and the timing of the donor and recipient operations. Establishing an understanding between the donor and recipient centers with respect to the operative plan with preoperative checklists and planned points of intraoperative communication during the donor and recipient hepatectomies would be necessary to prevent missteps. The parenchymal transection plane, preservation of middle hepatic branches from a right lobe (RL) graft, and location of the bile duct(s) transection are examples of items that need to be communicated between the donor and recipient teams as part of the planning process. The discussion and decisions as part of the pretransplant planning process are critical to the success of the recipient operation and the recipient's postoperative course. Many of these hurdles may be obviated if the swaps were performed at the same center, which would allow more control over logistical issues and intraoperative planning but entail increased resource utilization among operating rooms and the number of surgical teams.
Communication between centers during the donor and recipient surgery will be just as important as the pretransplant planning. The surgical teams need to trust each other's judgment and technical skills at the time of donation, which often involves intraoperative decisions that can impact the recipient allograft. Issues of unexpected adverse anatomy (ie, unexpected extra biliary ducts), unexpected donor liver quality, extrahepatic recipient pathology such as metastatic hepatocellular carcinoma (HCC), or donor or recipient hemodynamic instability may arise and impact the successful completion of the swap. Communication during the procedures would be essential to prevent irreversible steps in a donor or recipient surgery without confirming that both donors and both recipients are able to undergo donation and transplantation without risk of termination. Intraoperative discovery of additional extrahepatic ducts which were not anticipated based on predonation imaging is not an uncommon occurrence, and there should be a clear commitment from participating centers that this would not lead to termination of the swap unless issues of donor safety arose. Starting both donors simultaneously would be essential to avoid irreversible steps and assuage concerns about 1 of the donors reneging on a commitment to donate. Concerns about the intraoperative decisions might initially be mitigated by the participation of 1 of the recipient surgeons from the recipient hospital team with the donor operation. After the donor surgery is complete, the recipient surgeon could transport the donor allograft to the recipient hospital where another recipient surgeon had already started the hepatectomy. An alternative plan would use real-time intraoperative photography and videoconferencing of critical anatomic features to jointly make decisions between geographically distinct donor and recipient centers, thus negating the need for a recipient center surgeon to travel to the donor hospital.
The liver has less tolerance to prolonged cold ischemia than kidneys, which is an issue that may constrain LPE geographically and limit its overall potential to increase the number of liver transplants. Transferring a liver allograft between centers will require shorter transport cold times than what is currently accepted with the kidney. Despite initial concern that kidney outcomes might be compromised by increased cold ischemia related to organ travel, much of it on commercial flights, there does not appear to be any detriment to allograft outcomes. (40) One consideration to shorten the cold ischemia time is to move the donor (or recipient) involved in LPE to the other hospital where the intended recipient (or donor) is located so that the organ does not have to travel and thus eliminate the issue of an extended cold ischemia time. This will overcome the geographic constraints of LPE, expanding opportunities for transplant. Moving the donor or recipient was debated during the early years of KPE. However, patients were reluctant to leave the medical and surgical team where they had been evaluated, as well as their familial and community support system. Inherent logic would anticipate that this would be a similar sentiment in LPE and moving the organ rather the donor (or recipient) would engender wider acceptance.
Education and Consent
Besides the usual hazards associated with a LDLT, participants in LPE are exposed to additional risks that can occur as the direct result of an exchange. In KPE programs, these additional risks are addressed with an educational component specific to KPE risk, which is a requirement for pairs who wish to pursue this route to donation and transplantation (Table 3) .
Some of the issues that arise in the predonation and pretransplant evaluation include the following:
1. Unknown timing of the LPE for those within an exchange program. 2. Potential for a donor in a pair to back out after the reciprocal donor has donated. 3. Possibility that the donor organ may be found not to be transplantable at the time of surgery. 4. Risk that donor organ could be damaged and or compromised by the recovering team. 5. Unexpected difference in donor anatomy and/or lobar volume than what was anticipated from the predonation evaluation. 6. Risk of increased ischemic time related to delays in transport logistics.
Both UNOS and Centers for Medicare and Medicaid Services (CMS) have regulations that apply to KPE. (41, 42) Although not specifically defined, these would potentially apply to LPE. UNOS defines the basic outline of the educational component of KPE participants. CMS provides instruction for donor services that are not provided at the recipient hospital.
Future Considerations
If the benefit and the initial feasibility of LPE is accepted and established for simple swaps, a need to develop the infrastructure to support a more robust LPE program will ensue. This would include a registry and coordinating center for LPE pairs, algorithms for establishing priority among potential donor and recipient pairs, and a mechanism for monitoring outcomes.
Creating a central database and coordinating center to organize LPE would not be too dissimilar to that from KPE. Although data on HLA and levels of sensitization are generally not relevant to liver transplantation, detailed hepatic donor anatomy and size of the hepatic lobes would be necessary to inform potential swaps prior to a more detailed examination of donor anatomy, which can be accomplished through Unknown timing for LPE Potential for donor from another pair to renege Unanticipated findings in a donor or recipient at the time of surgery Surgical damage to donor lobe Potential that the transplant may not occur even after the donor and recipient have proceeded to the operating room Potential for logistical issues to cancel donation or transplantation or result in decrement in the allograft standardized classification schemes and secure online access to an image repository. The database would also contain additional health and demographic information relevant to donor selection. Centers that participate in LPE may wish to use uniform imaging modalities with interactive software and volumetric techniques to harmonize data across centers and decrease unexpected findings at the time of surgery. Standardization of the donor evaluation might include guidelines for predonation liver biopsy and other additional testing. Centers participating in an exchange would have secure online access to the database, allowing the recipient center to preselect potential donors, increasing matching efficiency.
With an increased number of donor and recipient pairs enrolled in LPE, a matching algorithm should be established to determine transplant priority. This may be one of the most difficult issues to resolve. MELD score could be used for priority, but the adverse outcomes of LDLT in high MELD patients are known. (43, 44) Other priorities might arise in an exchange algorithm, such as pediatric recipients, recipients who are more difficult to match based on blood type or size, or those with complications of liver disease not well measured by MELD (ie, hepatic encephalopathy, incapacitating pruritus, refractory ascites). Some consensus would need to be achieved as to what constitutes the best matching strategy. This remains to be resolved in KPE, where protocols can be separated into 2 broad categories, using either mathematical optimization or hierarchical matching rules. (45) We would anticipate that as LPE advanced after demonstration of robust donor safety and recipient outcomes in uncomplicated swaps, there would be an opportunity to explore the incorporation of altruistic donors to start chains. Although adopted by some LDLT centers, the greater risk of morbidity and mortality in living liver donation as compared with living kidney donation has dissuaded most centers from the routine inclusion of altruistic liver donors. The initiation of chains brings in other potentially complicating subjects that require future consideration such as bridge donors and how the LPE program might rectify a swap where the intended exchange donor fails to donate after their recipient has received a transplant.
LPE Ethics
LPE will raise ethical questions, old and new, which will need to be addressed. Although the principle of justice is an important determinant for the allocation and distribution of organs, performing LPE within a group of individuals will require a balancing act of respect for a person's autonomy, beneficence, and nonmaleficence. Ethical dilemmas relevant to all living donors will be relevant to individuals involved in a LPE. Characterizing and mitigating donor harms, ensuring donors are not financially burdened by undergoing donation, and creating registries to monitor longterm outcomes to improve informed consent will continue to be important issues. (46) Emerging ethical dilemmas within KPE will likely also affect LPE. How chains will end, using deceased donor grafts to initiate KPE chains, and the potential to unfairly advantage recipients in KPE are some of the current ethical issues that will be relevant to LPE. (37) There are several ethical concerns unique to LPE that merit further consideration. Double equipoise is the balance between the probability of harm to the donor and the recipient's survival benefit from LDLT. (47) This principle requires renewed consideration in the context of LPE. Miller poignantly describes a useful model for equipoise when it comes to LDLT involving a triangle with vectors for donor safety, expected recipient outcome, and need. (48, 49) Practical application of this principle requires consideration of the differential risk of the various anatomic hepatic lobectomies. A living liver donor has the possibility of donating a LLS, a left lobe (LL), or a RL of the liver. The risk of harm increases with increased liver volume donated. (47, 50, 51) Mortality rates between the 3 procedures are markedly different. The published mortality rate for LLS and LL donation is 0.1%, and RL donation is associated with a mortality risk of 0.5% in the United States. (52) (53) (54) Morbidity after RL donation is 28%, whereas it is 7.5% for LL donation and 9.3% for LLS donation. (55, 56) If a parent is unable to donate a LLS to their infant because of ABOi or graft size, they may pair with a recipient who is an adult in need of a RL, increasing the risk of harm for the donor parent (Fig. 3A) . Although this may be an acceptable risk for the parent who is trying to save a child, this may not be ethically acceptable in other scenarios. LPE could circumvent this dilemma by matching for size between LPE. However, the success of LPE will rely on a robust pool of pairs from which to draw from, and limitations to the pool will constrict its application and success. To ensure ethical principles are upheld, consideration as to the type of donor procedure and how this may change the risk to the donor in an LPE must be fully explained to the donor. The variation in risks of living liver donation which are specific to the extent of the donor hepatectomy are unique to LPE and are not encountered in KPE, where the risks of donation are small and relatively equivalent among the different donation techniques.
Expected recipient outcome is an important factor in weighing the ethical permissibility of performing a LDLT. LDLT for HCC has been independently associated with an increased risk of death and graft failure in some studies, but not all. (15) And although some data suggest there may be faster HCC recurrence rates in LDLT recipients, there are arguments to consider patients with tumors outside Milan criteria because they have the most to gain from undergoing LDLT. (57) (58) (59) Using the LPE example above, imagine a donor parent not only donates a RL instead of a LLS but is now donating a RL to an adult whose reason for transplant is HCC outside of Milan criteria. Using
Miller's triangle model for equipoise, the area of the triangle is now significantly changed from the donor parent's original desire to donate a LLS for their infant child (Fig. 3B) . Most donors are committed to seeing their intended recipient transplanted. However, LPE must consider whether the donor's desires outweigh medical judgment and shifting risk-benefit ratios that may not represent sound ethical decision making.
Part of the success of KPE is due to altruistic donors who trigger KPE chains with a nondirected donation. (4) There is a very limited experience with altruistic donors in LDLT given the larger and more variable risk of harm for living liver donors. If LPE aspires to maintain prolonged chains to maximize the number of matches and transplants that occur, the ethical tensions surrounding an altruistic living liver donor should be revisited. The first LDLT was performed with a parent-child pair due to the obvious motivation of the donor. (60) Further ethical analyses of LDLT use motivation as an important factor for determining psychological benefit for donors to offset the increasing risk to donor safety with procedures such as RL donation. (57) If altruistic liver donors step forward, it is imperative that a full social and psychological screen is conducted and that the altruistic donor is not under any undue influence to accept risk of harm.
Status in North America and Conclusions
At present, LPE has not been reported in the United States, although a handful of LPEs have occurred within single centers in Asia. (2, 3) A cautious and stepwise approach to LPE is necessary and appropriate, given the increased logistical challenges and, more importantly, the recognized increased morbidity and mortality of donor hepatectomy in LDLT. The demand for LDLT as a method to mitigate the liver allograft shortage and the growing experience with LDLT in the United States will undoubtedly lead to attempts at LPE. KPE provides a valuable framework to consider many of the logistical and ethical issues that may arise with future LPE programs. 
